Market Overview

Ultragenyx shares are up 8.3% after the FDA accepted the company's proposal to submit a New Drug Application (NDA) for UX007 for the treatment of long-chain fatty acid oxidation disorders.

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: WIIMMovers Trading Ideas

 

Related Articles (RARE)

Glaukos Shares Soar After Competing Stent Removed From Market

Trade Wars: $200 Billion Is Serious, 3 Scenarios And Currency Reactions For The Upcoming Escalation